Name : BCL9 Antibody, Cy7 Conjugated
Supplier : BIOSS PRIMARY CONJUGATED ANTIBODIES 1
Price :350
SKU : GEN8603234949
| Long name | Cy7 Conjugated, BCL9 Polyclonal Antibody |
| Category | Conjugated Primary Antibodies |
| Conjugation | Cy7 |
| Host Organism | Rabbit (Oryctolagus cuniculus) |
| Target Antigen | BCL9 |
| Specificity | This is a highly specific antibody against BCL9 |
| Modification | Unmodified |
| Modification site | None |
| Clonality | Polyclonal |
| Clone | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Source | KLH conjugated synthetic peptide derived from human BCL9 |
| Gene ID number | 101060700 |
| Tested applications | IF(IHC-P) |
| Recommended dilutions | IF(IHC-P)(1:50-200) |
| Crossreactivity | Mouse, Rat, Human |
| Crossreactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Antigen background | Bcl-9L exists as multiple alternatively spliced isoforms and is thought to be involved in tumorigenesis, Bcl-9L functions as a transcriptional activator that forms a complex with Parafibromin and Î, Expressed in breast tissue, Jacobsen syndrome, Jervell and Lange-Nielsen syndrome, Niemann-Pick disease, The gene encoding Bcl-9L maps to human chromosome 11, as well as in eye, hereditary angioedema and Smith-Lemli-Opitz syndrome are associated with defects in genes that maps to chromosome 11, lung, possibly playing a role in tumor transformation and metastasis, prostate and various carcinomas, which houses over 1, ², ², -catenin, -catenin and is thought promote the transcriptional activity of Parafibromin and enhance the neoplastic transforming activity of Î, 400 genes and comprises nearly 4% of the human genome, 499 amino acid protein that localizes to the nucleus and contains a specialized C-terminal domain that is important for its overall activity, Bcl-9L is a 1 |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA |
| Excitation Emission | 743nm/767nm |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24° |
| Conjugated | These antibodies are excite for emission at 650 nm and detected at a 676 nm wavelengths |
| Gene target | BCL9 Conjugated |
| Short name | Conjugated, BCL9 Antibody |
| Technique | antibodies against human proteins, antibodies for, antibody Conjugates, Antibody |
| Label | Cy7 |
| Alternative name | cyanine 7 coupled, B-cell CLL/lymphoma 9 (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | BCL9 and IDBG-101829 and ENSG00000116128 and 607, BCL9 and IDBG-633778 and ENSBTAG00000002422 and 788729, Bcl9 and IDBG-176803 and ENSMUSG00000038256 and 77578, LGS, beta-catenin binding, nuclei, this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005794 and this GO lgi apparatus and cellular component this GO :0005801 and cis- this GO lgi network and cellular component this GO :0008013 and beta-catenin binding and molecular function this GO :0014908 and myotube differentiation involved in skeletal muscle regeneration and biological process this GO :0035019 and somatic stem cell maintenance and biological process this GO :0035914 and skeletal muscle cell differentiation and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0060070 and canonical Wnt signaling pathway and biological process, this GO :0005515: protein binding, this GO :0005515: protein binding and also this GO :0008013: beta-catenin binding, this GO :0008013: beta-catenin binding, B-cell CLL/lymphoma 9 |
| Identity | 1008 |
| Gene | BCL9 |
| Long gene name | B-cell CLL/lymphoma 9 |
| Locus | 1q21, 2 |
| Discovery year | 1997-07-01 |
| GenBank acession | Y13620 |
| Entrez gene record | 607 |
| Pubmed identfication | 9490669 |
| RefSeq identity | NM_004326 |
| Havana BLAST/BLAT | OTTHUMG00000014031 |